Sunday, 22 December 2024
  
Login

Australia's most trusted
source of pharma news

Sunday, 22 December 2024
News

First state confirms RSV funding

Posted 6 March 2024 AM

Western Australia has become the first state or territory in Australia to confirm an immunisation program using Sanofi's Beyfortus, committing $11 million to offer babies protection against respiratory syncytial virus (RSV).

The state-funded program announced yesterday (Tuesday) will begin next month in preparation for winter when seasonal outbreaks of RSV often occur in children.

To see the whole article, please login

Popular

Who got booted to the May meet?
Best company Christmas gift is...
First out the door in '25?
He's back: Ex-GM wins CEO role
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2024 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home